spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BIO-Europe Spring 2018

12-14 March 2018
RAI Amsterdam, Europaplein, NL 1078 GZ, Amsterdam

The twelfth annual BIO-Europe Spring®conferenceis the premier springtime partnering conference for the biotechnology industry. For its 2018 edition, BIO-Europe Spring comes to Amsterdam, The Netherlands on March 12–14, 2018.

Theconference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and experience how you can have more partnering meetings in the three days of the conference than in the rest of the year.

Based on attendance at previous events, BIO-Europe Spring 2018 will bring together close to 2,600 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in over 15,000 partnering meetings.

 

Program please see website:  https://ebdgroup.knect365.com/bioeurope-spring/agenda/2

 
Print this page
Send to a friend
   
spacer
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

White Papers

News and Press Releases

Evolution Summit Press Release

“Many clinical trials today face delays because of difficulties in recruiting the required number of patients within the timeline. Sponsors need to look at other regions outside the US and Western Europe, that have access to a large pool of motivated patients, without compromising quality or anything else,” says Roman Hrynchuk, Chief Operating Officer, SanaClis. SanaClis was a solution provider at the Marcus Evans Evolution Summit March 2020.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement